TESTA, Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 929
AS - Asia 723
EU - Europa 346
SA - Sud America 101
AF - Africa 17
Totale 2.116
Nazione #
US - Stati Uniti d'America 892
SG - Singapore 316
CN - Cina 161
IT - Italia 88
BR - Brasile 84
DE - Germania 80
HK - Hong Kong 77
GB - Regno Unito 41
VN - Vietnam 41
IN - India 36
FI - Finlandia 27
CA - Canada 21
ID - Indonesia 21
RU - Federazione Russa 21
TR - Turchia 16
PL - Polonia 14
IQ - Iraq 13
MX - Messico 13
SE - Svezia 13
UA - Ucraina 12
CZ - Repubblica Ceca 11
FR - Francia 10
JP - Giappone 10
NL - Olanda 7
AR - Argentina 6
BD - Bangladesh 6
LT - Lituania 6
ZA - Sudafrica 6
JO - Giordania 5
AT - Austria 4
ES - Italia 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
PA - Panama 2
PK - Pakistan 2
TW - Taiwan 2
UY - Uruguay 2
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
MA - Marocco 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 2.116
Città #
Singapore 185
Ashburn 158
Santa Clara 80
Hong Kong 75
Beijing 68
Dallas 63
Fairfield 50
Chandler 48
New York 48
Los Angeles 45
Munich 40
Ferrara 36
Seattle 25
Houston 24
Helsinki 18
Jakarta 18
Wilmington 18
Cambridge 15
Warsaw 14
Woodbridge 14
Milan 13
Ho Chi Minh City 12
London 12
Shanghai 12
Atlanta 11
São Paulo 11
Baghdad 10
Princeton 10
Hanoi 9
Mexico City 9
Poplar 9
Brno 8
Falkenstein 8
Mānsa 8
San Diego 8
Tokyo 8
Toronto 8
Ankara 7
Bremen 7
Chennai 7
Montreal 7
Stockholm 7
Izmir 6
Moscow 6
Mumbai 6
Orem 6
Turku 6
Amman 5
Boardman 5
Brooklyn 5
Chicago 5
Dearborn 5
Florence 5
Frankfurt am Main 5
Hefei 5
Jacksonville 5
Johannesburg 5
Naples 5
Redwood City 5
Rome 5
Belo Horizonte 4
Bologna 4
Delhi 4
Jaipur 4
Manchester 4
Nanjing 4
Nuremberg 4
Rochester 4
San Mateo 4
St Petersburg 4
Bexley 3
Buffalo 3
Charlotte 3
City of London 3
Denver 3
Guangzhou 3
Kunming 3
Lappeenranta 3
Olomouc 3
Philadelphia 3
San Francisco 3
The Dalles 3
The Hague 3
Tianjin 3
Ann Arbor 2
Baku 2
Biên Hòa 2
Bolzano 2
Boston 2
Buenos Aires 2
Campinas 2
Curitiba 2
Gioia del Colle 2
Haiphong 2
Henderson 2
Itu 2
Jiaxing 2
Kanpur 2
Kansas City 2
Karbala 2
Totale 1.452
Nome #
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 154
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 153
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 143
An engineered factor X variant as a novel by-passing agent for hemophilia 124
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 120
Exploring spontaneous readthrough over recurrent F8 nonsense mutations: potential correlation with inhibitor risk? 120
Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches 119
An advanced method for the small-scale production of high-quality minicircle DNA 106
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 103
An integrated multi-tool analysis contributes elements to interpreting unclassified factor IX missense variants associated with haemophilia B 98
A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia 96
Translation termination codons in protein synthesis and disease 95
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 94
Engineered suppressor tRNAs as a novel correction approach for recurrent hemophilia A-causing nonsense mutations 75
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 71
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 70
Base and Prime Editors as new correction approaches for recurrent Hemophilia A Nonsense Mutations 61
Tailored collagen binding confers distinct functional properties to engineered factor IX fusion proteins in hemophilia B mouse model 61
Design of an engineered coagulation factor X as a novel by-passing agent for hemophilia 61
Reverting highly frequent f8 nonsense mutations: base and prime editing approach for hemophilia A 56
A novel tailored correction approach for recurrent hemophilia-causing nonsense mutations through AntiCodon-Engineered suppressor tRNAs 56
Engineered tRNAs as a novel tailored correction approach to restore protein biosynthesis and function from hemophilia-causing nonsense mutations 49
The heterozygous p.R854Q variant is responsible for the conformational changes in the D’D3 domain of the von Willebrand Factor, by weakening its interaction with factor VIII: in-silico analysis 48
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties 31
Von Willebrand factor natural variants of the arginine 1205: in-silico analysis of the protein structural changes and its interactions with the macrophagic scavenger receptor LRP1 18
Totale 2.182
Categoria #
all - tutte 11.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 563
Totale 11.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 5 18 14 3 4 12 1
2021/202280 17 7 1 6 1 3 1 2 4 7 3 28
2022/2023115 11 14 5 9 16 8 11 11 14 2 4 10
2023/2024128 6 6 7 1 4 33 4 10 10 4 5 38
2024/2025626 23 8 47 16 58 112 15 30 75 65 97 80
2025/20261.012 208 80 103 251 278 92 0 0 0 0 0 0
Totale 2.182